A. Mosaic (FRT42D Dark), and Dark
Egfr (FRT42D
Dark) eyes. In both eyes the homozygous mutant tissue is pigmented (w). B. Region of chromosome 2R that failed to complement L.3.1 by deficiency mapping (2R:21,497,290..21,806,350). Arrow denotes location of Egfr gene. B is adapted from flybase.org (Gramates et al., 2017).
Description
An EMS screen was conducted utilizing the Flp/FRT system to identify mutations that caused an array of phenotypic alterations in the size of the eye including the ratio of mutant to wild type tissue (red over white) or the developmental patterning of the mosaic eye. This screen was done in the genetic background of blocked apoptosis in the homozygous mutant cells to identify conditional regulators of cell growth and eye development (Kagey et al., 2012). The block in apoptosis in the mosaic mutant tissue was achieved by using a FRT42D Darkchromosome as a starting point for the EMS mutagenesis (Akdemir et al., 2006). The Dark allele was generated by an imprecise excision of the P{lacW}ArkCD4, this allele retains the w (Akdemir et al., 2006) One of the mutants identified was L.3.1 which generated a small rough eye mosaic phenotype, with a smaller percentage of pigmented tissue than the FRT42D, Darkcontrol (Figure 1A). The Darkmosaic eye is approximately 60% pigmented tissue, while the Dark mosaic eye was smaller overall and approximately 50% mutant tissue (w). The ‘rough eye’ phenotype indicates a disruption in the ommatidial organization. In both images the pigmented (w) tissue is homozygous mutant and the unpigmented tissue is homozygous wild type.
Figure 1.
A. Mosaic (FRT42D Dark), and Dark
Egfr (FRT42D
Dark) eyes. In both eyes the homozygous mutant tissue is pigmented (w). B. Region of chromosome 2R that failed to complement L.3.1 by deficiency mapping (2R:21,497,290..21,806,350). Arrow denotes location of Egfr gene. B is adapted from flybase.org (Gramates et al., 2017).
The genetic mapping of the location of mutant L.3.1 was done by two independent groups of undergraduate researchers at the University of Detroit Mercy and University of Evansville in undergraduate genetics laboratory courses as part of the Fly-CURE consortium (Bieser et al., 2018). Complementation mapping was conducted independently and the results confirmed between groups. Virgin females from the FRT42D L.3.1 Dark stock were mated in series to male flies from the 87 deficiency stocks that comprise the Bloomington Stock Center 2R Deficiency Kit (only stocks distal to the FRT42D site were used for mapping) (Cook et al., 2012). Mutant L.3.1 failed to complement Deficiency stock Df(2R)BSC664 (2R:21,341,647..21,872,028), while complementing the flanking overlapping deficiencies Df(2R)BSC821 and Df(2R)BSC597. This left a region of failure to complement of 2R:21,497,290..21,806,350, which is pictured above in Figure 1 B. Lethal alleles of candidate genes within this region were mated independently to L.3.1 to test for complementation. L.3.1 failed to complement an apparent loss of function allele EgfrDworkin et. al. 2006), indicating that L.3.1 is likely a novel Egfr allele, Egfr
Reagents
FRT42D Dark (Akdemir et al., 2006)FRT42D Dark (this manuscript)Ey>Flp; FRT42D (BDSC 5616)y; P{w=lacW}Egfr/CyO (BDSC 10385)Bloomington Drosophila Stock Center 2R Deficiency Kit (Cook et al., 2012):w Df(2R)BSC664/SM6aw; Df(2R)BSC821, P+PBac{ w =XP3.RB5}BSC821/SM6aw Df(2R)BSC597/SM6a
Authors: Fatih Akdemir; Robert Farkas; Po Chen; Gabor Juhasz; Lucia Medved'ová; Miklos Sass; Lai Wang; Xiaodong Wang; Suganthi Chittaranjan; Sharon M Gorski; Antony Rodriguez; John M Abrams Journal: Development Date: 2006-03-15 Impact factor: 6.868
Authors: R Kimberley Cook; Stacey J Christensen; Jennifer A Deal; Rachel A Coburn; Megan E Deal; Jill M Gresens; Thomas C Kaufman; Kevin R Cook Journal: Genome Biol Date: 2012 Impact factor: 17.906
Authors: L Sian Gramates; Steven J Marygold; Gilberto Dos Santos; Jose-Maria Urbano; Giulia Antonazzo; Beverley B Matthews; Alix J Rey; Christopher J Tabone; Madeline A Crosby; David B Emmert; Kathleen Falls; Joshua L Goodman; Yanhui Hu; Laura Ponting; Andrew J Schroeder; Victor B Strelets; Jim Thurmond; Pinglei Zhou Journal: Nucleic Acids Res Date: 2016-10-30 Impact factor: 16.971
Authors: Eric P Spana; Amanda B Abrams; Katharine T Ellis; Jason C Klein; Brandon T Ruderman; Alvin H Shi; Daniel Zhu; Andrea Stewart; Susan May Journal: G3 (Bethesda) Date: 2020-09-02 Impact factor: 3.154
Authors: Alysia D Vrailas-Mortimer; Nitish Aggarwal; Neha N Ahmed; Ian M Alberts; Masa Alhawasli; Ibrahim A Aljerdi; Brooke M Allen; Ahmad M Alnajar; Michael A Anderson; Ryan Armstong; Chace C Avery; Eric J Avila; Tyra N Baker; Soolmaz Basardeh; Natasha A Bates; Farrah N Beidas; Ashton C Bosler; Deja M Brewer; Ryan S Buenaventura; Natalie Jl Burrell; Alyn P Cabrera-Lopez; Amairani B Cervantes-Gonzalez; Raymond P Cezar; Joselyn Coronel; Corinne Croslyn; Konnor R Damery; Lucero Diaz-Alavez; Nupur P Dixit; Dilcia L Duarte; Amanda R Emke; Katherine English; Audrey A Eshun; Samuel R Esterly; Arnold J Estrada; Mark Feng; Meghan M Freund; Niko Garcia; Charandeep S Ghotra; Haddia Ghyasi; Christa Sa Hale; Luci Hulsman; Lindsey Jamerson; Austin K Jones; Madeline Kuczynski; Takailah N Lacey-Kennedy; Mindy J Lee; Tala Mahjoub; Molly C Mersinger; Alyssa D Muckerheide; David W Myers; Karen Nielsen; Paul J Nosowicz; Jacinda A Nunez; Amy C Ortiz; Tulsi T Patel; Natalie N Perry; W Storm A Poser; Deisy M Puga; Cathrine Quam; Paulina Quintana-Lopez; Piper Rennerfeldt; Nicholas M Reyes; Ian G Rines; Cally Roberts; Daniel B Robinson; Kalina M Rossa; Gloria J Ruhlmann; Jeremy Schmidt; John R Sherwood; Dimyana H Shonoda; Hannah Soellner; Juan C Torrez; Mayukah Velide; Zachary Weinzapfel; Alisa C Ward; Kayla L Bieser; Julie A Merkle; Joyce C Stamm; Richard L Tillett; Jacob D Kagey Journal: MicroPubl Biol Date: 2021-01-18